OK Biotech Co., Ltd. (TPE:4155)

OK Biotech Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 26, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	1,884	2,050	3,007	3,656	2,643	2,217
Market Cap Growth	-41.63%	-31.83%	-17.75%	38.36%	19.21%	-12.17%
Enterprise Value	2,633	2,882	3,384	3,420	2,738	2,319
Last Close Price	13.35	14.50	20.09	24.35	22.82	18.51
PE Ratio	23.44	24.87	32.00	1240.26	18.42	51.00
PS Ratio	1.21	1.32	1.80	3.07	1.78	1.76
PB Ratio	0.73	0.80	1.17	1.53	1.43	1.30
P/TBV Ratio	0.92	1.00	1.49	1.54	1.46	1.34
P/OCF Ratio	5.91	6.43	45.63	1246.60	10.99	101.24
EV/Sales Ratio	1.69	1.85	2.03	2.87	1.85	1.84
EV/EBITDA Ratio	13.09	14.30	27.02	56.71	16.50	38.83
EV/EBIT Ratio	24.27	26.71	59.15	-	26.89	286.69
Debt / Equity Ratio	0.39	0.39	0.28	0.14	0.42	0.43
Debt / EBITDA Ratio	5.04	5.04	5.57	5.23	4.60	11.49
Net Debt / Equity Ratio	0.27	0.27	0.17	-0.01	0.08	0.05
Net Debt / EBITDA Ratio	3.42	3.42	3.43	-0.55	0.87	1.49
Net Debt / FCF Ratio	-8.43	-8.43	-1.38	0.08	-3.11	-1.56
Asset Turnover	0.41	0.41	0.49	0.39	0.51	0.47
Inventory Turnover	2.29	2.29	3.02	2.44	2.85	2.97
Quick Ratio	1.35	1.35	1.18	1.48	1.26	1.50
Current Ratio	2.28	2.28	1.98	2.28	1.84	2.13
Return on Equity (ROE)	3.78%	3.78%	4.29%	-0.07%	7.70%	1.83%
Return on Assets (ROA)	1.79%	1.79%	1.06%	-0.25%	2.17%	0.19%
Return on Invested Capital (ROIC)	3.08%	3.22%	1.79%	0.11%	4.19%	0.34%
Return on Capital Employed (ROCE)	3.30%	3.30%	1.90%	-0.50%	4.60%	0.40%
Earnings Yield	4.38%	4.02%	3.13%	0.08%	5.43%	1.96%
FCF Yield	-4.79%	-3.98%	-10.33%	-11.67%	-1.75%	-2.58%
Dividend Yield	2.25%	2.07%	1.49%	1.23%	4.89%	4.90%
Payout Ratio	53.11%	53.11%	46.95%	4906.38%	66.17%	303.37%
Buyback Yield / Dilution	1.20%	1.20%	-14.02%	1.41%	-9.95%	-18.84%
Total Shareholder Return	3.45%	3.27%	-12.53%	2.64%	-5.06%	-13.94%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.